Bharat Biotech Vaccine
-
{
- All
- News
- Videos
-
Bharat Biotech, Sydney University Announce Pact To Advance Vaccine Research
Bharat Biotech and the University of Sydney Infectious Diseases Institute Tuesday announced a memorandum of understanding between them to advance vaccine research initiatives, strengthen academic-industry partnerships and
-
Panel Allows Bharat Biotech To Give 3rd Dose Of Covaxin In Trial: Report
The expert panel of India's drug regulator DCGI has allowed Bharat Biotech to give a third dose of Covaxin to a few volunteers in its clinical trials of the COVID-19 vaccine, sources said.
-
"Far-Reaching Announcement": Bharat Biotech On Covid Vaccine Budget
Covaxin maker Bharat Biotech on Monday described as "far reaching" initiative the allocation of Rs 35,000 crore for COVID-19 vaccination in the Union Budget and said it would help the country become free of the viral disease.
-
4 New Units To Manufacture 700 Million Vaccine Doses A Year: Bharat Biotech
Bharat Biotech, which has been accorded Emergency Use Authorisation from the drug regulator for its COVID-19 vaccine Covaxin, today said they are setting up four vaccine manufacturing facilities with a combined capacity of 700 million doses per year.
-
"Bharat Biotech Vaccine Could Be Back-Up For Now," Says AIIMS Chief
Bharat Biotech's coronavirus vaccine, which is still undergoing clinical trial, is likely to be the "back-up" vaccine in the coming days, Dr Randeep Guleria, the chief of Delhi's All-India Institute of Medical Sciences said today as two vaccines got emergency approval from the country's drug regulator. Politics has started over the approval to Cova...
-
Bharat Biotech, Sydney University Announce Pact To Advance Vaccine Research
Bharat Biotech and the University of Sydney Infectious Diseases Institute Tuesday announced a memorandum of understanding between them to advance vaccine research initiatives, strengthen academic-industry partnerships and
-
Panel Allows Bharat Biotech To Give 3rd Dose Of Covaxin In Trial: Report
The expert panel of India's drug regulator DCGI has allowed Bharat Biotech to give a third dose of Covaxin to a few volunteers in its clinical trials of the COVID-19 vaccine, sources said.
-
"Far-Reaching Announcement": Bharat Biotech On Covid Vaccine Budget
Covaxin maker Bharat Biotech on Monday described as "far reaching" initiative the allocation of Rs 35,000 crore for COVID-19 vaccination in the Union Budget and said it would help the country become free of the viral disease.
-
4 New Units To Manufacture 700 Million Vaccine Doses A Year: Bharat Biotech
Bharat Biotech, which has been accorded Emergency Use Authorisation from the drug regulator for its COVID-19 vaccine Covaxin, today said they are setting up four vaccine manufacturing facilities with a combined capacity of 700 million doses per year.
-
"Bharat Biotech Vaccine Could Be Back-Up For Now," Says AIIMS Chief
Bharat Biotech's coronavirus vaccine, which is still undergoing clinical trial, is likely to be the "back-up" vaccine in the coming days, Dr Randeep Guleria, the chief of Delhi's All-India Institute of Medical Sciences said today as two vaccines got emergency approval from the country's drug regulator. Politics has started over the approval to Cova...
